We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
Cap. Flow
+$823M
Cap. Flow %
0.99%
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$431M
2
DAL icon
Delta Air Lines
DAL
+$318M
3
DE icon
Deere & Co
DE
+$282M
4
RHI icon
Robert Half
RHI
+$270M
5
CW icon
Curtiss-Wright
CW
+$265M

Sector Composition

Rank Sector Weight
1 Financials 21.07%
2 Technology 14.6%
3 Industrials 13.72%
4 Healthcare 11.92%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
251
CDW
CDW
$18.4B
$39.1M 0.05%
244,157
-3,184
-1% -$579K
GFF icon
252
Griffon
GFF
$4.29B
$38.8M 0.05%
550,340
-7,778
-1% -$574K
HWC icon
253
Hancock Whitney
HWC
$6.19B
$37.7M 0.05%
725,408
-4,333
-0.6% -$244K
FCN icon
254
FTI Consulting
FCN
$5.04B
$37.3M 0.05%
226,574
+91,182
+67% +$16.4M
ENOV icon
255
Enovis
ENOV
$1.7B
$37.1M 0.04%
970,980
-77,552
-7% -$3.29M
INGR icon
256
Ingredion
INGR
$6.48B
$36.9M 0.04%
273,851
+210,737
+334% +$27.8M
IPG
257
DELISTED
Interpublic Group of Companies
IPG
$35.9M 0.04%
1,323,918
-6,107
-0.5% -$168K
CW icon
258
Curtiss-Wright
CW
$26.9B
$35.6M 0.04%
112,074
-784,876
-88% -$265M
TMHC icon
259
Taylor Morrison
TMHC
$35.4M 0.04%
590,930
-3,417
-0.6% -$213K
CHX
260
DELISTED
ChampionX
CHX
$35.2M 0.04%
1,215,579
-590
-0% -$17.2K
WBS icon
261
Webster Financial
WBS
$12.5B
$34.7M 0.04%
673,424
+187,648
+39% +$10.4M
IWD icon
262
iShares Russell 1000 Value ETF
IWD
$82.2B
$34.5M 0.04%
185,424
-77,995
-30% -$14.9M
CNXC icon
263
Concentrix
CNXC
$1.55B
$34M 0.04%
624,274
+91,130
+17% +$4.36M
FA icon
264
First Advantage
FA
$3.58B
$34M 0.04%
2,421,573
+216,282
+10% +$3.63M
MEOH icon
265
Methanex
MEOH
$4.12B
$33.8M 0.04%
987,790
-1,744
-0.2% -$78.3K
HAE icon
266
Haemonetics
HAE
$3.75B
$33.4M 0.04%
531,431
-4,831
-0.9% -$329K
AROC icon
267
Archrock
AROC
$6.19B
$33.3M 0.04%
1,310,677
+13,865
+1% +$374K
ACT icon
268
Enact Holdings
ACT
$6.7B
$32.9M 0.04%
944,899
+11,708
+1% +$391K
SOBO
269
South Bow Corp
SOBO
$7.75B
$32.8M 0.04%
+1,294,731
New +$32.4M
ADEA icon
270
Adeia
ADEA
$2.77B
$32.7M 0.04%
2,525,597
-38,217
-1% -$532K
SNEX icon
271
StoneX
SNEX
$8.99B
$31.7M 0.04%
919,501
-794
-0.1% -$26.6K
COLB icon
272
Columbia Banking Systems
COLB
$8.84B
$31.3M 0.04%
1,274,611
+3,322
+0.3% +$88.5K
AX icon
273
Axos Financial
AX
$5.64B
$31.2M 0.04%
504,815
+77,730
+18% +$5.27M
SMPL icon
274
Simply Good Foods
SMPL
$941M
$30.8M 0.04%
886,864
-334,421
-27% -$12.1M
CPRX
275
DELISTED
Catalyst Pharmaceutical
CPRX
$30.6M 0.04%
1,275,325
-16,543
-1% -$373K

Similar funds

Boston Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
  • Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
  • Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
  • Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
  • Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
  • Boston Partners opened 76 new positions and closed 81 in Q1 2025.
  • Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.

Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.